198 related articles for article (PubMed ID: 31794337)
1. Distance Traveled to Head and Neck Cancer Provider: A Measure of Socioeconomic Status and Access.
Massa ST; Liebendorfer AP; Zevallos JP; Mazul AL
Otolaryngol Head Neck Surg; 2020 Feb; 162(2):193-203. PubMed ID: 31794337
[TBL] [Abstract][Full Text] [Related]
2. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
3. Distance traveled to glioblastoma treatment: A measure of the impact of socioeconomic status on survival.
Bird CE; Traylor JI; Youssef M; Abdullah KG
Clin Neurol Neurosurg; 2021 Oct; 209():106909. PubMed ID: 34500342
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
[TBL] [Abstract][Full Text] [Related]
5. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival.
Graboyes EM; Ellis MA; Li H; Kaczmar JM; Sharma AK; Lentsch EJ; Day TA; Hughes Halbert C
Cancer; 2018 Aug; 124(15):3181-3191. PubMed ID: 29932220
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
Lee NCJ; Kelly JR; An Y; Park HS; Judson BL; Burtness BA; Husain ZA
Cancer; 2019 Jun; 125(12):2018-2026. PubMed ID: 30748002
[TBL] [Abstract][Full Text] [Related]
8. Access to Lung Transplantation in the United States: The Potential Impact of Access to a High-volume Center.
Chan EG; Hayanga JWA; Tuft M; Morrell MR; Sanchez PG
Transplantation; 2020 Jul; 104(7):e199-e207. PubMed ID: 32569004
[TBL] [Abstract][Full Text] [Related]
9. Explaining Racial Disparities in Surgically Treated Head and Neck Cancer.
Jassal JS; Cramer JD
Laryngoscope; 2021 May; 131(5):1053-1059. PubMed ID: 33107610
[TBL] [Abstract][Full Text] [Related]
10. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
11. Impact of geography and travel distance on outcomes in epithelial ovarian cancer: a national cancer database analysis.
Daruvala A; Lucas FL; Sammon J; Darus C; Bradford L
Int J Gynecol Cancer; 2021 Feb; 31(2):209-214. PubMed ID: 33214215
[TBL] [Abstract][Full Text] [Related]
12. Is patient travel distance associated with survival on phase II clinical trials in oncology?
Lamont EB; Hayreh D; Pickett KE; Dignam JJ; List MA; Stenson KM; Haraf DJ; Brockstein BE; Sellergren SA; Vokes EE
J Natl Cancer Inst; 2003 Sep; 95(18):1370-5. PubMed ID: 13130112
[TBL] [Abstract][Full Text] [Related]
13. Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients.
Farquhar DR; Masood MM; Lenze NR; Tasoulas J; Sheth S; Lumley C; Blumberg J; Yarbrough WG; Zevallos J; Weissler MC; Zanation AM; Hackman TG; Olshan AF
Head Neck; 2023 Dec; 45(12):2981-2989. PubMed ID: 37767817
[TBL] [Abstract][Full Text] [Related]
14. The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.
Ryan S; Serrell EC; Karabon P; Mills G; Hansen M; Hayn M; Menon M; Trinh QD; Abdollah F; Sammon JD
J Urol; 2018 Feb; 199(2):424-429. PubMed ID: 29030318
[TBL] [Abstract][Full Text] [Related]
15. Geographic Access to High-Volume Care Providers and Survival in Patients with Bone Sarcomas: Nationwide Patterns in the United States.
Fujiwara T; Ogura K; Alaqeel M; Healey JH
J Bone Joint Surg Am; 2022 Aug; 104(16):1426-1437. PubMed ID: 35730765
[TBL] [Abstract][Full Text] [Related]
16. Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for bladder cancer.
Haddad AQ; Singla N; Gupta N; Raj GV; Sagalowsky AI; Margulis V; Lotan Y
Urology; 2015 Apr; 85(4):876-82. PubMed ID: 25817110
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.
Wong TH; Skanthakumar T; Nadkarni N; Nguyen HV; Iyer NG
Cancer; 2017 Jun; 123(11):1998-2005. PubMed ID: 28135397
[TBL] [Abstract][Full Text] [Related]
18. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
19. Patient Choice of Nonsurgical Treatment Contributes to Disparities in Head and Neck Squamous Cell Carcinoma.
Parhar HS; Anderson DW; Janjua AS; Durham JS; Prisman E
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1057-1064. PubMed ID: 29436282
[TBL] [Abstract][Full Text] [Related]
20. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
